SILO Pharma Inc (NASDAQ:SILO)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 1.61. At the close of trading, the stock’s price was $0.62, to imply a decrease of -2.15% or -$0.01 in intraday trading. The SILO share’s 52-week high remains $4.50, putting it -625.81% down since that peak but still an impressive 33.87% since price per share fell to its 52-week low of $0.41. The company has a valuation of $4.43M, with an average of 0.3 million shares in intraday trading volume over the past 10 days and average of 964.27K shares over the past 3 months.

SILO Pharma Inc (NASDAQ:SILO) trade information

After registering a -2.15% downside in the last session, SILO Pharma Inc (SILO) has traded red over the past five days. The 5-day price performance for the stock is -2.50%, and 24.16% over 30 days. With these gigs, the year-to-date price performance is -37.44%. Short interest in SILO Pharma Inc (NASDAQ:SILO) saw shorts transact 0.8 million shares and set a 0.35 days time to cover.

SILO Dividends

SILO Pharma Inc has its next earnings report out on 2024-Mar-25. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

SILO Pharma Inc (NASDAQ:SILO)’s Major holders

SILO Pharma Inc insiders hold 9.50% of total outstanding shares, with institutional holders owning 3.45% of the shares at 3.81% float percentage. In total, 3.45% institutions holds shares in the company, led by VIRTU FINANCIAL LLC. As of 2024-06-30, the company held over 41848.0 shares (or 1.3709% of shares), all amounting to roughly $41000.0.

The next major institution holding the largest number of shares is FINANCIAL ADVOCATES INVESTMENT MANAGEMENT with 23938.0 shares, or about 0.7842% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $23938.0.